Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study

被引:2
|
作者
Grzegorzewska, Alicja E. [1 ]
Mostowska, Adrianna [1 ]
Warchol, Wojciech [2 ]
Jagodzinski, Pawel P. [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Wielkopolska, Poland
[2] Poznan Univ Med Sci, Dept Ophthalmol & Optometry, PL-60806 Poznan, Wielkopolska, Poland
关键词
HCV RNA; Hemodialysis; IFNL4; rs368234815; PON1; variants; Spontaneous HCV clearance; HIGH-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; VIRAL CLEARANCE; MOLECULAR-BASIS; POLYMORPHISM; ASSOCIATION; GENOTYPE; DISEASE; ENZYME; TRANSCRIPTION;
D O I
10.1186/s12879-021-06597-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background To explore associations between PON1 rs854560, rs662, 705,379, HCV clearance, and interactions between tested PON1 single nucleotide variants (SNVs) and interferon-lambda 4 gene (IFNL4) rs368234815 variant in hemodialyzed individuals. Methods The study included 83 HD individuals who spontaneously resolved HCV infection (all had known IFNL4 rs368234815 variant) and 104 individuals with persistently positive blood tests for HCV RNA (102 were IFNL4 rs368234815 variant successfully genotyped). We genotyped PON1 by high-resolution melt analysis (rs662) or predesigned TaqMan SNV Genotyping Assay (rs854560, rs705379). We used a logistic regression model to assess the association between genetic data and HCV outcome while adjusting for clinical confounding variables. Epistatic interactions between tested PON1 SNVs and IFNL4 rs368234815 were analyzed by the multifactor dimensionality reduction method. Results In the recessive inheritance model, PON1 rs662 GG (OR 9.94, 95% CI 1.20-82.7, P = 0.022) and rs854560 TT (OR 4.31, 95% CI 1.62-11.5, P = 0.003) genotypes were associated with a higher probability for HCV clearance. The haplotype composed of rs662A_rs854560A_rs705379 was not associated with spontaneous HCV clearance. The IFNL4 rs368234815 TT/TT variant was equally distributed among individuals bearing different PON1 SNVs. The epistatic gene-gene analysis did not reveal the interaction between tested PON1 SNVs and IFNL4 rs368234815 (P = 0.094). Regression model, including the PON1 rs662 GG genotype, the PON1 rs854560 genotype, the IFNL4 rs368234815 TT/TT genotype, age at RRT onset, RRT duration, and chronic glomerulonephritis as possible explanatory variables for spontaneous HCV clearance, showed that significant predictors of spontaneous HCV clearance were the IFNL4 rs368234815 TT/TT genotype (OR 2.607, 95% CI 1.298-5.235, P = 0.007), PON1 rs854560 TT (OR 6.208, 1.962-19.644, P = 0.002), PON1 rs662 GG (OR 10.762, 1.222-94.796, P = 0.032), and RRT duration (OR 0.930, 95% CI 0.879-0.984, P = 0.011). Conclusion In HD individuals, PON1 rs662 GG and rs854560 TT are associated with a higher frequency of spontaneous HCV clearance.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
    Alicja E. Grzegorzewska
    Adrianna Mostowska
    Wojciech Warchoł
    Paweł P. Jagodziński
    BMC Infectious Diseases, 21
  • [2] Paraoxonase 1 Gene Variants Concerning Spontaneous HCV Clearance in Hemodialysis Patients
    Grzegorzewska, Alicja E.
    Mostowska, Adrianna
    Warchol, Wojciech J.
    Jagodzinski, Pawel P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 282 - 283
  • [3] PARAOXONASE 1 (PON1) GENE POLYMORPHISMS, PON1 EXPRESSION IN PBMCS, AND SERUM PON1 ACTIVITY CONCERNING DYSLIPIDEMIA AND RELATED COMORBIDITIES IN HEMODIALYSIS (HD) PATIENTS
    Grzegorzewska, Alicja Ewa
    Lwanczyk-Skalska, Ewa
    Adamska, Paulina
    Niepolski, Leszek
    Mostowska, Adrianna
    Warchol, Wojciech
    Jagodzinski, Pawel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1598 - 1598
  • [4] Effect of Paraoxonase1 (PON1) gene polymorphisms on PON1 activity, HDL, LDL and MDA levels in women with polycystic ovary syndrome (PCOS): A case-control study
    Jeelani, Humira
    Ganie, Mohd Ashraf
    Amin, Shajrul
    Fatima, Qudsia
    Kawa, Iram Ashaq
    Manzoor, Saika
    Parvez, Tabasum
    Ahmad, Dar Nazir
    Rashid, Fouzia
    META GENE, 2019, 20
  • [5] Paraoxonase 1 (PON1) gene polymorphism and haplotype analysis in type 2 diabetes mellitus: a case-control study in the south Iranian population
    Moasser, Elham
    Azarpira, Negar
    Dalini, Ali Ghorbani
    Shirazi, Babak
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2018, 38 (01) : 62 - 68
  • [6] Serum Activities of Paraoxonase 1 (PON1) in Predicting Liver Damage Among Patients Diagnosed With Hepatocellular Carcinoma: A Case-Control Study
    Bade, Jyotchna D.
    Veeramalla, Vydehi
    Naidu, M. Balachandra R.
    Lalitha, Danturty L.
    Ponnada, Sarath Chandra
    Kandi, Venkataramana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [7] PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study
    Ragkousis, Antonios
    Kazantzis, Dimitrios
    Georgalas, Ilias
    Theodossiadis, Panagiotis
    Kroupis, Christos
    Chatziralli, Irini
    GENES, 2024, 15 (06)
  • [8] Paraoxonase 1 (PON1) gene polymorphism and haplotype analysis in type 2 diabetes mellitus: a case–control study in the south Iranian population
    Elham Moasser
    Negar Azarpira
    Ali Ghorbani dalini
    Babak Shirazi
    International Journal of Diabetes in Developing Countries, 2018, 38 : 62 - 68
  • [9] Association of M55L and Q192R polymorphisms of paraoxonase 1 gene (PON1) with recurrent pregnancy loss risk: A case-control study
    Alizadeh, Mehdi
    Nasiri, Mahboobeh
    Samadi, Morteza
    Ghasemi, Nasrin
    Moradi, Ali
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2021, 19 (06) : 559 - 568
  • [10] Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: A case-control study
    Hatzakis, A
    Katsoulidou, A
    Kaklamani, E
    Touloumi, G
    Koumantaki, Y
    Tassopoulos, NC
    Karvountzis, G
    Gioustozi, A
    Hadziyannis, S
    Trichopoulos, D
    INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (01) : 51 - 53